Cigna Group (NYSE:CI) Given New $350.00 Price Target at Truist Financial

Cigna Group (NYSE:CIGet Free Report) had its price objective raised by Truist Financial from $320.00 to $350.00 in a research report issued on Tuesday,MarketScreener reports. The brokerage currently has a “buy” rating on the health services provider’s stock. Truist Financial’s price target suggests a potential upside of 20.13% from the company’s current price.

Several other analysts have also weighed in on CI. Weiss Ratings restated a “hold (c-)” rating on shares of Cigna Group in a report on Monday, December 29th. The Goldman Sachs Group cut their price target on Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a research note on Tuesday, November 4th. Royal Bank Of Canada reduced their target price on Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a report on Friday, February 6th. Jefferies Financial Group boosted their target price on shares of Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Finally, TD Cowen upped their target price on shares of Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research note on Monday, February 9th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $330.63.

View Our Latest Stock Report on CI

Cigna Group Price Performance

Shares of NYSE CI opened at $291.35 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.76. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The business has a 50-day moving average of $277.40 and a 200-day moving average of $283.75. The company has a market capitalization of $77.83 billion, a price-to-earnings ratio of 13.14, a PEG ratio of 1.01 and a beta of 0.27.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. During the same period in the prior year, the company posted $6.64 earnings per share. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, equities analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Hedge Funds Weigh In On Cigna Group

Institutional investors and hedge funds have recently bought and sold shares of the stock. Pathway Financial Advisers LLC grew its position in shares of Cigna Group by 2.3% during the 2nd quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock valued at $496,000 after purchasing an additional 34 shares in the last quarter. Armstrong Advisory Group Inc. increased its stake in Cigna Group by 17.7% in the third quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock valued at $65,000 after acquiring an additional 34 shares during the last quarter. HM Payson & Co. lifted its position in Cigna Group by 0.9% in the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock worth $1,091,000 after buying an additional 35 shares during the last quarter. Carr Financial Group Corp boosted its stake in shares of Cigna Group by 5.3% in the 3rd quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock valued at $204,000 after purchasing an additional 36 shares in the last quarter. Finally, Natural Investments LLC grew its stake in shares of Cigna Group by 2.0% during the third quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock valued at $531,000 after buying an additional 36 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

About Cigna Group

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Analyst Recommendations for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.